American Journal of Kidney Diseases
Volume 54, Issue 4 , Pages 638-646 , October 2009

Prehypertension, Obesity, and Risk of Kidney Disease: 20-Year Follow-up of the HUNT I Study in Norway

  • John Munkhaugen, MD

      Affiliations

    • Faculty of Medicine, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
    • Corresponding Author InformationAddress correspondence to John Munkhaugen, MD, Department of Cancer Research and Molecular Medicine, St Olav University Hospital, N-7006 Trondheim, Norway
    • ,
  • Stian Lydersen, PhD

      Affiliations

    • Faculty of Medicine, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
    • ,
  • Tor-Erik Widerøe, MD, PhD

      Affiliations

    • Faculty of Medicine, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
    • Department of Nephrology, St Olav University Hospital, Trondheim, Norway
    • ,
  • Stein Hallan, MD, PhD

      Affiliations

    • Faculty of Medicine, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
    • Department of Nephrology, St Olav University Hospital, Trondheim, Norway

Received 28 November 2008 ,Accepted 27 March 2009.

References 

  1. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28
  2. Meguid EL, Nahas A, Bello AK. Chronic kidney disease: The global challenge. Lancet. 2005;365:331–340
  3. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165:923–928
  4. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13–18
  5. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572
  6. Mitka M. Experts ponder treating prehypertension. JAMA. 2006;295:2125–2126
  7. Schunkert H. Pharmacotherapy for prehypertension—Mission accomplished?. N Engl J Med. 2006;354:1742–1744
  8. Perry HM, Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995;25:587–594
  9. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49:800–805
  10. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003;41:1341–1345
  11. Reynolds K, Gu D, Muntner P, et al. A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol. 2007;18:1928–1935
  12. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int. 1997;51:850–854
  13. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004;164:2113–2118
  14. Agyemang C, van Valkengoed I, van den Born BJ, Stronks K. Prevalence and determinants of prehypertension among African Surinamese, Hindustani Surinamese, and white Dutch in Amsterdam, The Netherlands: The SUNSET study. Eur J Cardiovasc Prev Rehabil. 2007;14:775–781
  15. Nguyen S, Hsu CY. Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens. 2007;16:71–76
  16. Reynolds K, Gu D, Muntner P, et al. Body mass index and risk of ESRD in China. Am J Kidney Dis. 2007;50:754–764
  17. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861–1867
  18. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–1105
  19. Rutkowski P, Klassen A, Sebekova K, Bahner U, Heidland A. Renal disease in obesity: The need for greater attention. J Ren Nutr. 2006;16:216–223
  20. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625–633
  21. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–1053
  22. Holmen J, Forsen L, Hjort PF, Midthjell K, Waaler HT, Bjorndal A. Detecting hypertension: Screening versus case finding in Norway. BMJ. 1991;302:219–222
  23. Obesity: Preventing and managing the global epidemic (Report of a WHO consultation). World Health Organ Tech Rep Ser. 2000;894:1–253i-xii
  24. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report (National Institutes of Health). Obes Res. 1998;6(suppl 2):S51–S209
  25. Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12:132–137
  26. Sundman L, Jakobsson S, Nystrom L, Rosen M. A validation of cause of death certification for ischaemic heart disease in two Swedish municipalities. Scand J Prim Health Care. 1988;6:205–211
  27. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359:800–809
  28. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med. 2007;167:2490–2496
  29. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: Cohort study. BMJ. 2008;337:236A;(abstr)
  30. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). In: Geneva, Switzerland: WHO; 1977;p. 1
  31. World Health Organization. International Statistical Classification of Diseases, Tenth Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992;
  32. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. (ed 3). Philadelphia, PA: Lippincott Williams & Wilkins; 2008;
  33. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452–456
  34. Newgard CD, Haukoos JS. Advanced statistics: Missing data in clinical research—Part 2: Multiple imputation. Acad Emerg Med. 2007;14:669–678
  35. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: A gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087–1091
  36. Sanches FM, Avesani CM, Kamimura MA, et al. Waist circumference and visceral fat in CKD: A cross-sectional study. Am J Kidney Dis. 2008;52:66–73
  37. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–880
  38. Elsayed EF, Tighiouart H, Weiner DE, et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis. 2008;52:49–57
  39. Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52:29–38
  40. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis. 2008;52:39–48
  41. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913
  42. Garrison RJ, Kannel WB, Stokes J, Castelli WP. Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med. 1987;16:235–251
  43. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int. 2001;59:1498–1509
  44. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis. 2002;39:1–11
  45. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension. 1995;26:610–615
  46. Skrondal A. Interaction as departure from additivity in case-control studies: A cautionary note. Am J Epidemiol. 2003;158:251–258
  47. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479–487

 Originally published online as doi: 10.1053/j.ajkd.2009.03.023 on June 11, 2009.

PII: S0272-6386(09)00719-7

doi: 10.1053/j.ajkd.2009.03.023

American Journal of Kidney Diseases
Volume 54, Issue 4 , Pages 638-646 , October 2009

Article Tools

* Image Usage & Resolution